中性粒细胞趋化三肽在慢性阻塞性肺疾病中的作用机制
被引量:1
摘要
慢性阻塞性肺疾病(COPD)在研究和治疗上最主要的障碍是缺乏一种与疾病的严重程度和评价预后相关的标志物。近年发现,
出处
《实用医学杂志》
CAS
北大核心
2013年第3期501-503,共3页
The Journal of Practical Medicine
参考文献18
-
1Yoon H I,Sin D D. Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease:a critical review of the literature[J].Drugs,2011,(14):1821-1837.
-
2Pfister R R,Haddox J L,Sommers C I. Identification and synthesis of chemotactic tripeptides from alkalidegraded whole cornea.A study of N-acetyl-proline-glycine-proline and N-methyl-proline-glycine-proline[J].Investigative Ophthalmology & Visual Science,1995,(07):1306-1316.
-
3Pfister R R,Haddox J L,Sommers C I. Injection of chemoattractants into normal cornea:a model of inflammation after alkali injury[J].Investigative Ophthalmology & Visual Science,1998,(09):1744-1750.
-
4O'Reilly P J,Gaggar A,Blalock J E. Interfering with extracellular matrix degradation to blunt inflammation[J].Current Opinion in Pharmacology,2008,(03):242-248.
-
5Weathington N M,van Houwelingen A H,Noerager B D. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation[J].Nature Medicine,2006,(03):317-323.
-
6Gaggar A,Jackson P L,Noerager B D. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation[J].Journal of Immunology,2008,(08):5662-5669.
-
7O'Reilly P J,Hardison M T,Jackson P L. Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide,PGP,from collagen[J].Journal of Neuroimmunology,2009,(1-2):51-54.
-
8O'Reilly P,Jackson P L,Noerager B. N-alpha-PGP and PGP,potential biomarkers and therapeutic targets for COPD[J].Respiratory Research,2009.38.
-
9Hardison M T,Brown M D,Snelgrove R J. Cigarette smoke enhances chemotaxis via acetylation of prolineglycine-proline[J].Front Biosci (Elite Ed),2012.2402-2409.
-
10Snelgrove R J,Jackson P L,Hardison M T. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation[J].Science,2010,(6000):90-94.
同被引文献7
-
1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8227
-
2VaJay G G, Franitza S, Schor H. Combinatorial signals byinflammatory cytokines and chemokines mediate leukocyte interactions with dextracellular matrix [J]. J Leukoc Biol, 2001,69(6) :885-892.
-
3Chen H, Wang D, Wang X. Role of Airway Epithelium-Origin Chemokines and their Receptors in COPD [J]. Journal of Epithelial Biology & Pharmacology, 2010,3 : 26-33.
-
4LEE S C, Brummet M E, Shahabuddin S, et al. Cutaneous injection of human subje-cts with ifflammatory protein-I alpha induces signific-antrecruitment of neutriphils and monecyets[J. J Inmmnol, 2000,164(6) : 3392-3401.
-
5Sehmelzer C, Lorenz G, Rimbach G, et al. In vitro effects of the reduced form of coengynle QlO on secretion levels of TNF-a and chemokines in response to LPS in the human monocytic cell line THP- 1 [ J ]. JClin Biochem Nutr, 2009,44 ( 1 ) : 62-66.
-
6Salvatore C M, Techasaensiri C, Taliabue C, et al. Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of mycoplasma pneumonia pneumonia [J]. Antimicrob Agents Chemother, 2009,53 (4) : 1546-1551.
-
7高占成.降钙素原对诊断慢性阻塞性肺疾病急性加重的应用价值[J].中华结核和呼吸杂志,2013,36(4):313-314. 被引量:34
二级引证文献9
-
1赵晓风.N-乙酰半胱氨酸辅助治疗对稳定期COPD患者气道炎症、重塑等的调节作用[J].海南医学院学报,2016,22(12):1250-1253. 被引量:27
-
2杨阳,刘行仁.巨噬细胞刺激蛋白表达水平与慢性阻塞性肺疾病患者肺功能的关系[J].广东医学,2017,38(3):397-401. 被引量:9
-
3张晓瑜,闫蕊.巨噬细胞刺激蛋白在慢性阻塞性肺疾病发病机制中的作用研究[J].临床医学研究与实践,2018,3(2):88-89. 被引量:5
-
4田丁元,党连生.趋化因子MIP-1α与不同肺部疾病的研究进展[J].系统医学,2019,4(5):196-198.
-
5袁彬,谈山峰,陈秋萍,姚卫民,赖维光,扈友庄,方芳.AECOPD患者血清LTB4、MIP-1α、MSP与肺功能指标的相关性[J].广东医科大学学报,2019,37(6):645-647. 被引量:3
-
6赵晓风.肺宁颗粒联合头孢唑肟钠治疗老年慢性支气管炎急性发作期的临床研究[J].现代药物与临床,2021,36(3):567-570. 被引量:14
-
7王丽.金荞麦片联合茶碱缓释片治疗老年慢性支气管炎疗效及对血清学指标的影响[J].现代药物与临床,2021,36(7):1480-1483. 被引量:9
-
8吴彩军,晏军,李莉,曹艳晨,杨露露,周恒,齐晓晓,李雪建.不同中医证型慢性阻塞性肺疾病患者血清炎症因子水平比较[J].中国医师杂志,2023,25(2):165-169. 被引量:2
-
9武琰娇,张娜娜,柏少锋.异丙托溴铵联合乙酰半胱氨酸对慢性阻塞性肺疾病患者血浆与诱导痰巨噬细胞刺激蛋白表达及肺功能影响[J].临床军医杂志,2019,47(3):281-283. 被引量:18
-
1钟思干,陈爱文,杨飞,郑如义,廖火城,刘锦全.急性冠脉综合征患者脂蛋白(a)水平与其近期预后的相关性研究[J].中国全科医学,2012,15(28):3243-3244. 被引量:8
-
2陆健.贫血在心力衰竭患者中常见并与不良预后相关[J].国外医学(心血管疾病分册),2003,30(6):388-388.
-
3陈胜德.心力衰竭患者预后相关预测指标的研究进展[J].按摩与康复医学,2015,6(13):48-49. 被引量:1
-
4柏晋梅,李锡兰.影响慢性肺心病预后相关因素分析[J].山西医药杂志,1998,27(5):443-445.
-
5张剑平,姚上志,张社卿.细菌性脑膜炎抗生素的临床应用及预后相关因素分析(附30例报告)[J].哈尔滨医科大学学报,1999,33(5):407-408.
-
6朱金水,朱励,余小虎,俞华芳,达炜.氧化苦参碱对肝纤维化患者IL-6、IL-8、IL-10水平影响[J].中国免疫学杂志,2003,19(3):191-192. 被引量:51
-
7康建华.血糖水平与急性冠脉综合征患者预后相关[J].国外医学(心血管疾病分册),2004,31(1):57-58.
-
8赵文治.慢性阻塞性肺病并发呼吸衰竭预后相关因素分析[J].第四军医大学学报,2009,30(21):2453-2453. 被引量:1
-
9黎汝,汪晓红.老年社区获得性肺炎的预后相关高危因素分析[J].临床肺科杂志,2013,18(5):856-857. 被引量:12
-
10陈东海,季乃军,童丽军,樊必夫,王成尧,梅益斌,李付远,考验.慢性心力衰竭患者血清醛固酮水平的变化及其临床意义[J].心脏杂志,2005,17(3):256-257. 被引量:6